ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 622155 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 622155; 2) Community: the network communities that were significantly associated with the response to NSC 622155; 3) Molecule: the relationships between components within communities and NSC 622155; 4) MDR: the compounds that were significantly associated with the NSC 622155.

NSC Compound Enrichment Correlation
NSC 676345 Pyrimidine-2,4-diamine, 6-chloro-N(4)- [[1-(hydroxymethyl)-3-(2-phenylethyl)cyclobutyl]methyl]- 0.0348993771550531 0.19034194
NSC 684906 Null 0.0348993771550531 0.2137937
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.0348993771550531 0.21006867
NSC 697535 Null 0.0348993771550531 0.13916394
NSC 726217 Combretastatin A4-analogue 0.0348993771550531 0.08110639
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.0348993771550531 0.039021576
NSC 733149 Null 0.0348993771550531 0.12336915
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0348993771550531 0.2839697
NSC 743532 Null 0.0348993771550531 0.11972981
NSC 750873 2,5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-(3-hydroxy-4-methoxyphenyl)-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol 0.0348993771550531 0.05965515
Total:57  Current:36    [First] [Prev] [Next] [Last]